Patients with rheumatoid arthritis and other inflammatory diseases are at increased risk for developing infections like shingles. Many of these patients take immunosuppressive drugs to treat the inflammation and pain associated with those diseases. A new study examined whether patients beginning anti-T-N-F therapy are at a higher risk for developing shingles infection. Catherine Dolf explains in this week’s JAMA Report.
